Two stem cell specialists will soon become the latest to take their chances on the public markets: Cardio3 Biosciences and Cellular Dynamics have both announced plans for initial public offerings (IPOs).
Cellular Dynamics (based in Madison, Wisconsin) is hoping to raise up to $57.3m in its IPO on Nasdaq. The company, which will trade under the ticker symbol ICEL, said the...